Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
209.26B
Market cap209.26B
Price-Earnings ratio
11.26
Price-Earnings ratio11.26
Dividend yield
2.67%
Dividend yield2.67%
Average volume
11.66M
Average volume11.66M
High today
$47.17
High today$47.17
Low today
$46.06
Low today$46.06
Open price
$46.37
Open price$46.37
Volume
10.88M
Volume10.88M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

Simply Wall St 6h
Novo Nordisk Stock And 2 Dividend Growers With Strong Cash Flow

Eurozone manufacturing and services activity are both improving in 2026, with composite growth at a nine month high. That kind of steady economic pulse often ke...

Novo Nordisk Stock And 2 Dividend Growers With Strong Cash Flow
Reuters 1d
Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump - Reuters

...

Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump - Reuters
Simply Wall St 2d
Is Novo Nordisk Undervalued As Oral Semaglutide Progress Shapes Its Growth Story?

Novo Nordisk (NYSE:NVO) continues to attract attention as investors weigh its role in obesity and diabetes care against recent share price moves. The stock clos...

Is Novo Nordisk Undervalued As Oral Semaglutide Progress Shapes Its Growth Story?

Analyst ratings

58%

of 36 ratings
Buy
33.3%
Hold
58.3%
Sell
8.3%

More NVO News

TipRanks 2d
Novo Nordisk Adds a New Early-Stage Obesity Drug to Its Pipeline

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident i...

24/7 Wall St. 2d
Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold?

Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold? By Vandita Jadeja Published Aug 19, 12:00PM EDT Quick Read LLY dominates the GLP-1 race with 48% revenue...

Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold?
TipRanks 2d
Novo Nordisk testing lower doses of oral Wegovy, Reuters reports

Novo Nordisk (NVO) is testing lower doses of oral Wegovy to identify the minimum effective dose, a move that could improve tolerability, accessibility, and econ...

24/7 Wall St. 2d
Stock Forecast: The Market is Sleeping on Eli Lilly's Next $1 Trillion Opportunity

Stock Forecast: The Market is Sleeping on Eli Lilly’s Next $1 Trillion Opportunity By Vandita Jadeja Published Aug 19, 9:30AM EDT Quick Read LLY earns a BUY a...

Stock Forecast: The Market is Sleeping on Eli Lilly's Next $1 Trillion Opportunity
The Wall Street Journal 2d
Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills

The lowest current starter dose of Wegovy available is 1.5 milligrams. Hannah Beier / Reuters Novo Nordisk NOVO.B -0.51 %decrease; down pointing triangle is st...

Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills
TipRanks 2d
United Laboratories Warns of Sharp First-Half Profit Decline

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Seeking Alpha 2d
Novo Nordisk tests low-dose Wegovy pill in new study

Novo Nordisk (NVO) is testing lower doses of its Wegovy obesity pill in a new study aimed at determining how low patients can go in their dose while still achie...

Novo Nordisk tests low-dose Wegovy pill in new study

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.